Explore our materials

Filters

Results (4448)

François Venter

MD, FCP, PhD

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

Adherence Considerations in Choice of ARV Regimens - Francois Venter

Andrea Calcagno

MD, DTM&H

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

State of the Art: Clinical Pharmacology of INSTI - Andrea Calcagno

Chia-Jui Yang

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

Recap the Second Edition

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

Roundtable Discussion: Resistance Considerations in Optimal Use of INSTI

Kiat Ruxrungtham

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

HIV Drug Resistance in Asia Clinical Application - Kiat Ruxrungtham, MD

Chia-Jui Yang

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

Optimal Use of DTG in Treatment Experienced Patients - Chia-Jui Yang, MD

Anne-Geneviève Marcelin

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

State of the Art: Resistance to INSTI - Anne - Geneviève Marcelin, PharmD, PhD

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

Roundtable Discussion: Benefits of 2nd Generation INSTI in Routine Clinical Practice

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

The 2nd Generation INSTI usage - Fujie Zhang

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

Integrase inhibitors: A unique Mechanism of Action - José Luis Blanco Arévalo

Video

HIV

Chinese HIV Clinical Forum Educational Series 2020 - 2021

Review of DTG and BIC Registrational Studies -José R Arribas

HTD

Huu Thuy Do

MD, MPH

Video

HIV

Asian Stigma & Discrimination Forum 2019

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

Adherence Considerations in Choice of ARV Regimens - Francois Venter

State of the Art: Clinical Pharmacology of INSTI - Andrea Calcagno

Recap the Second Edition

Roundtable Discussion: Resistance Considerations in Optimal Use of INSTI

HIV Drug Resistance in Asia Clinical Application - Kiat Ruxrungtham, MD

Optimal Use of DTG in Treatment Experienced Patients - Chia-Jui Yang, MD

State of the Art: Resistance to INSTI - Anne - Geneviève Marcelin, PharmD, PhD

Roundtable Discussion: Benefits of 2nd Generation INSTI in Routine Clinical Practice

The 2nd Generation INSTI usage - Fujie Zhang

Integrase inhibitors: A unique Mechanism of Action - José Luis Blanco Arévalo

Review of DTG and BIC Registrational Studies -José R Arribas

Stigma Discrimination--Health Care Perspective: How Deep is the Problem? - Huu Thuy Do, MD, MPH